GIORDANO, Silvia

GIORDANO, Silvia  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 167 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. 1994 PONZETTO C; BARDELLI A; ZHEN Z; MAINA F; DALLA ZONCA P; GIORDANO S; GRAZIANI A; PANAYOTOU G; P. COMOGLIO
A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation 1997 S. ANASTASI; S. GIORDANO; O. STHANDIER; G. GAMBAROTTA; R. MAIONE; P.M. COMOGLIO; P. AMATI
A point mutation in the MET oncogene abrogates metastasis without affecting transformation. 1997 GIORDANO S; BARDELLI A; ZHEN Z; MENARD S; PONZETTO C; COMOGLIO PM
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity 2006 PETRELLI A; CIRCOSTA P; GRANZIERO L; MAZZONE M; PISACANE A; FENOGLIO S; COMOGLIO P; GIORDANO S
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 2017 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. 2010 S. Corso;E. Ghiso;V. Cepero;J. R. Sierra;C. Migliore;A. Bertotti;L. Trusolino;P. M. Comoglio;S. Giordano
Activation of RAS family members confers resistance to ROS1 targeting drugs. 2014 Cargnelutti M;Corso S;Pergolizzi M;Mévellec L;Aisner DL;Dziadziuszko R;Varella-Garcia M;Comoglio PM;Doebele RC;Vialard J;Giordano S
Altered regulation of receptor associated-tyrosine kinases in human tumors 1989 P.M. Comoglio; M.F. Di Renzo; G. Gaudino; S. Giordano; L. Naldini; C. Ponzetto
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 2013 Bardelli A*;Corso S*;Bertotti A*;Hobor S;Valtorta E;Siravegna G;Sartore-Bianchi A;Scala E;Cassingena A;Zecchin D;Apicella M;Migliardi G;Galimi F;Lauricella C;Zanon C;Perera T;Veronese S;Corti G;Amatu A;Gambacorta M;Diaz LA Jr;Sausen M;Velculescu VE;Comoglio P;Trusolino L;Di Nicolantonio F;Giordano S;Siena S (*Co-First Authors)
Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products 2007 COMOGLIO Paolo Maria; VIGNA Elisa; GIORDANO Silvia
Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells 2020 Rizzolio S.; Corso S.; Giordano S.; Tamagnone L.
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study 2018 Pietrantonio, Filippo; Fucà, Giovanni; Morano, Federica; Gloghini, Annunziata; Corso, Simona; Aprile, Giuseppe; Perrone, Federica; De Vita, Ferdinando; Tamborini, Elena; Tomasello, Gianluca; Gualeni, Ambra Vittoria; Ongaro, Elena; Busico, Adele; Giommoni, Elisa; Volpi, Chiara Costanza; Laterza, Maria Maddalena; Corallo, Salvatore; Prisciandaro, Michele; Antista, Maria; Pellegrinelli, Alessandro; Castagnoli, Lorenzo; Pupa, Serenella M; Pruneri, Giancarlo; de Braud, Filippo; Giordano, Silvia; Cremolini, Chiara; Di Bartolomeo, Maria
Biosynthesis of the protein encoded by the c-met proto-oncogene 1989 Giordano S; Di Renzo MF; Narsimhan RP; Cooper CS; Rosa C; Comoglio PM
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 2018 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Leuci, Valeria; Rotolo, Ramona; Donini, Chiara; Basiricò, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Sibilia, Maria; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy. 2015 Petrelli, A; Carollo, R; Cargnelutti, M; Iovino, F; Callari, M; Cimino, D; Todaro, M; Mangiapane, Lr; Giammona, A; Cordova, A; Montemurro, F; Taverna, D; Daidone, Mg; Stassi, G; Giordano, S.
C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells. 1998 LIN S; RUSCIANO D; LORENZONI P; HARTMANN G; BIRCHMEIER W; GIORDANO S; COMOGLIO P; BURGER MM
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. 1991 PONZETTO C ;GIORDANO S ;PEVERALI F ;DELLA VALLE G ;ABATE ML ;VAULA G ;COMOGLIO PM
C-terminal truncated forms of Met, the hepatocyte growth factor receptor. 1991 PRAT M ;CREPALDI T ;GANDINO L ;GIORDANO S ;LONGATI P ;COMOGLIO P
Cancer therapy: can the challenge be MET? 2005 CORSO S; COMOGLIO PM; GIORDANO S
Il cancro 2009 G. Del Sal; S. Giordano